Literature DB >> 23199531

Cytochrome P450-mediated drug metabolism in the brain.

Sharon Miksys1, Rachel F Tyndale.   

Abstract

Cytochrome P450 enzymes (CYPs) metabolize many drugs that act on the central nervous system (CNS), such as antidepressants and antipsychotics; drugs of abuse; endogenous neurochemicals, such as serotonin and dopamine; neurotoxins; and carcinogens. This takes place primarily in the liver, but metabolism can also occur in extrahepatic organs, including the brain. This is important for CNS-acting drugs, as variation in brain CYP-mediated metabolism may be a contributing factor when plasma levels do not predict drug response. This review summarizes the characterization of CYPs in the brain, using examples from the CYP2 subfamily, and discusses sources of variation in brain CYP levels and metabolism. Some recent experiments are described that demonstrate how changes in brain CYP metabolism can influence drug response, toxicity and drug-induced behaviours. Advancing knowledge of brain CYP-mediated metabolism may help us understand why patients respond differently to drugs used in psychiatry and predict risk for psychiatric disorders, including neurodegenerative diseases and substance abuse.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23199531      PMCID: PMC3633708          DOI: 10.1503/jpn.120133

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  163 in total

Review 1.  Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.

Authors:  Stefano Porcelli; Chiara Fabbri; Edoardo Spina; Alessandro Serretti; Diana De Ronchi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-07-08       Impact factor: 4.481

2.  Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes.

Authors:  J Tang; Y Cao; R L Rose; A A Brimfield; D Dai; J A Goldstein; E Hodgson
Journal:  Drug Metab Dispos       Date:  2001-09       Impact factor: 3.922

3.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities.

Authors:  S Bhamre; H K Anandatheerathavarada; S K Shankar; M R Boyd; V Ravindranath
Journal:  Arch Biochem Biophys       Date:  1993-03       Impact factor: 4.013

6.  The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.

Authors:  Ewa Bromek; Anna Haduch; Władysława A Daniel
Journal:  Eur J Pharmacol       Date:  2009-10-08       Impact factor: 4.432

Review 7.  Multiple roles for nicotine in Parkinson's disease.

Authors:  Maryka Quik; Luping Z Huang; Neeraja Parameswaran; Tanuja Bordia; Carla Campos; Xiomara A Perez
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

8.  Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

Authors:  Jiang Yue; Sharon Miksys; Ewa Hoffmann; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2008-01       Impact factor: 6.186

9.  Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6.

Authors:  A Llerena; G Edman; J Cobaleda; J Benítez; D Schalling; L Bertilsson
Journal:  Acta Psychiatr Scand       Date:  1993-01       Impact factor: 6.392

10.  Rodent model of nicotine abstinence syndrome.

Authors:  D H Malin; J R Lake; P Newlin-Maultsby; L K Roberts; J G Lanier; V A Carter; J S Cunningham; O B Wilson
Journal:  Pharmacol Biochem Behav       Date:  1992-11       Impact factor: 3.533

View more
  32 in total

Review 1.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

2.  Smoking, psychiatric illness and the brain.

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

3.  Astrocytes protect against diazinon- and diazoxon-induced inhibition of neurite outgrowth by regulating neuronal glutathione.

Authors:  Daniella M Pizzurro; Khoi Dao; Lucio G Costa
Journal:  Toxicology       Date:  2014-02-19       Impact factor: 4.221

4.  Subacute nicotine co-exposure has no effect on 2,2',3,5',6- pentachlorobiphenyl disposition but alters hepatic cytochrome P450 expression in the male rat.

Authors:  Marianna Stamou; Eric Uwimana; Brenna M Flannery; Izabela Kania-Korwel; Hans-Joachim Lehmler; Pamela J Lein
Journal:  Toxicology       Date:  2015-10-14       Impact factor: 4.221

5.  Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.

Authors:  R T Miller; S Miksys; E Hoffmann; R F Tyndale
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 6.  Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations.

Authors:  Yumi Yamamoto; Meindert Danhof; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2017-03-09       Impact factor: 4.009

7.  Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Cole Tolledo; Marlaina R Stocco; Sharon Miksys; Frank J Gonzalez; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-03-18       Impact factor: 5.590

8.  Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.

Authors:  Teresa Coccini; Sarah Vecchio; Marta Crevani; Uliana De Simone
Journal:  Neurotox Res       Date:  2018-06-22       Impact factor: 3.911

9.  Antiretroviral protease inhibitors accelerate glutathione export from viable cultured rat neurons.

Authors:  Maria Brandmann; Michaela C Hohnholt; Charlotte Petters; Ralf Dringen
Journal:  Neurochem Res       Date:  2014-03-25       Impact factor: 3.996

Review 10.  Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes.

Authors:  Yurong Song; Chenxi Li; Guangzhi Liu; Rui Liu; Youwen Chen; Wen Li; Zhiwen Cao; Baosheng Zhao; Cheng Lu; Yuanyan Liu
Journal:  Clin Pharmacokinet       Date:  2021-03-16       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.